Hero MotoCorp Share Price Live Updates: Hero MotoCorp’s Market Performance Today
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Day: July 20, 2026
Bajaj Finance Share Price Live Updates: Bajaj Finance’s Price and Performance Overview
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Kotak Bank Share Price Live Updates: Kotak Bank’s Current Price and Market Performance
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
ONGC Share Price Live Updates: ONGC’s Stock Price and Performance Overview
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Cipla Share Price Live Updates: Cipla’s Daily Change Overview
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Asian Paints Share Price Live Updates: Asian Paints sees a minor dip in price
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
M&M Share Price Live Updates: Current Trading Status of M&M
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Why is market falling today? Sensex slumps 600 points, Nifty tests 24,200. 6 factors behind the selloff
Indian stock markets traded lower on Monday, impacted by Iran-US tensions. Sensex and Nifty experienced significant declines, reflecting investor concerns over rising oil prices. Tech Mahindra and Bharti Airtel shares saw gains, while Axis and HDFC Bank shares dropped. Broader markets also traded with marginal losses, with private banks leading the decline. Despite the overall…
Natco Pharma shares surge 5% after US FDA’s tentative nod Olaparib tablets
Natco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent version of AstraZeneca’s Lynparza. The drug addresses a $1.4-billion U.S. market opportunity. The company will manufacture the product, while Alembic Pharmaceuticals will handle its U.S. commercialisation.
PNB shares jump 6% as Q1 profit soars 214%, beats Street estimates. What next?
Punjab National Bank shares rose sharply on Monday after the PSU lender reported a 214% YoY jump in Q1FY27 net profit, beating Street estimates. Strong asset quality, lower provisions and improving margins prompted JM Financial to upgrade the stock and Motilal Oswal to reiterate its Buy rating with a higher target.